We are actively evaluating new in-licensing and acquisition opportunities to further build our pipeline of novel, differentiated therapeutics for dermatology-related indications.
We focus on drug candidates that:
- Satisfy an unmet human need or provide a newer, improved alternative to existing therapies in the dermatology market
- Have demonstrated positive results in animal disease models or human studies
- Are capable of or have been patent protected
- Possess significant sales potential in major global markets
If you have a technology that you believe may be of interest to us, please email INFO@BRICKELLBIO.COM.